CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with ...
LAS VEGAS, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Sage (FTSE: SGE), the market leader in cloud business management solutions, today kicks off its revamped annual conference for Sage Intacct customers. The ...
Announced positive topline data from pivotal WATERFALL Study of zuranolone in patients with MDD showing statistically significant and clinically meaningful reduction in depressive symptoms at Day 15, ...
TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Sage (FTSE: SGE), the market leader in cloud business management solutions, today announced the 2021 Sage Circle of Excellence Accounting Awards winners.
Throughout Sage Therapeutics’ development of zuranolone, the biotech has been consistent in the messaging for its experimental depression drug: Whereas existing therapies may require weeks to work and ...
From being projected as a mid-round draft pick to going undrafted. That's the story of wide receiver Sage Surratt. The Lions swooped in and picked him up immediately after the 2021 NFL Draft came to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback